Cite
NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
MLA
Giogha, Cristina, et al. “NleB2 from Enteropathogenic Escherichia Coli Is a Novel Arginine-Glucose Transferase Effector.” PLoS Pathogens, vol. 17, no. 6, June 2021, pp. 1–29. EBSCOhost, https://doi.org/10.1371/journal.ppat.1009658.
APA
Giogha, C., Scott, N. E., Wong Fok Lung, T., Pollock, G. L., Harper, M., Goddard-Borger, E. D., Pearson, J. S., & Hartland, E. L. (2021). NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector. PLoS Pathogens, 17(6), 1–29. https://doi.org/10.1371/journal.ppat.1009658
Chicago
Giogha, Cristina, Nichollas E. Scott, Tania Wong Fok Lung, Georgina L. Pollock, Marina Harper, Ethan D. Goddard-Borger, Jaclyn S. Pearson, and Elizabeth L. Hartland. 2021. “NleB2 from Enteropathogenic Escherichia Coli Is a Novel Arginine-Glucose Transferase Effector.” PLoS Pathogens 17 (6): 1–29. doi:10.1371/journal.ppat.1009658.